These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20420782)

  • 1. [Correlation between serum progesterone level at the day with human chorionic gonadotrophin administration and the outcome of pregnancy in in-vitro fertilization].
    Xi QP; Mao YD; Gao Y; Ding W; Wang W; Ma X; Diao FY; Huang J; Qian XQ; Cai LB; Feng T; Yan ZJ; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):118-23. PubMed ID: 20420782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration: detrimental cutoff levels and new treatment strategy?
    Martínez F
    Fertil Steril; 2011 Jun; 95(8):e61; author reply e62. PubMed ID: 21536272
    [No Abstract]   [Full Text] [Related]  

  • 4. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?
    Azem F; Tal G; Lessing JB; Malcov M; Ben-Yosef D; Almog B; Amit A
    Gynecol Endocrinol; 2008 Jul; 24(7):368-72. PubMed ID: 18645708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.
    Moraloğlu Ö; Tonguc EA; Özel M; Özakşit G; Var T; Sarikaya E
    Arch Gynecol Obstet; 2012 Mar; 285(3):857-62. PubMed ID: 21938500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort.
    Moffitt DV; Queenan JT; Shaw R; Muasher SJ
    Fertil Steril; 1997 Feb; 67(2):296-301. PubMed ID: 9022606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF; Diamond MP; Abuzeid M
    Fertil Steril; 2010 Feb; 93(2):554-69. PubMed ID: 19362305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
    Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
    J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum progesterone at human chorionic gonadotropin injection significantly correlate with female age.
    Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A
    Minerva Ginecol; 2005 Aug; 57(4):477-82. PubMed ID: 16170294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
    Sharara FI; McClamrock HD
    Hum Reprod; 1999 Nov; 14(11):2777-82. PubMed ID: 10548621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy.
    Elgindy EA
    Fertil Steril; 2011 Apr; 95(5):1639-44. PubMed ID: 21324450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
    Huang Y; Wang EY; Du QY; Xiong YJ; Guo XY; Yu YP; Sun YP
    Reprod Biol Endocrinol; 2015 Aug; 13():82. PubMed ID: 26238449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?
    Kyrou D; Popovic-Todorovic B; Fatemi HM; Bourgain C; Haentjens P; Van Landuyt L; Devroey P
    Hum Reprod; 2009 Nov; 24(11):2902-9. PubMed ID: 19671625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
    Kably Ambe A; Estévez González S; Carballo Mondragón E
    Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dosage of human chorionic gonadotropins influences the relationship between progesterone and cycle outcome during in vitro fertilization-embryo transfer.
    Prien SD; Canez MS; Messer RH
    Int J Fertil Womens Med; 2000; 45(4):258-63. PubMed ID: 10997481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent IVF failure is associated with elevated progesterone on the day of hCG administration.
    Liu L; Zhou F; Lin X; Li T; Tong X; Zhu H; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):78-83. PubMed ID: 24012150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and midluteal phase blood estradiol levels after ovum pickup and pregnancy rates after ICSI cycles.
    Levi R; Ozyurek SE; Goker EN; Tavmergen EH
    J Reprod Med; 2004 Feb; 49(2):108-14. PubMed ID: 15018439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.